Nightstar

Latest articles

28d
Reuters
$1 million price tag in spotlight as gene therapy becomes realityand quality of life benefits - especially in a condition like blindness - that
Reuters / Posted 28 days ago
and quality of life benefits - especially in a condition like blindness - that manufacturers argue should be recognized. Nightstar Therapeutics (NITE.O) CEO David Fellows, whose company is also developing gene therapies for eye disorders, said... Read more

In this news